Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA, USA; Division of Vascular and Endovascular Surgery, University of Virginia, Charlottesville, VA, USA.
Department of Cardiovascular Surgery, Shizuoka Medical Centre, Shizuoka, Japan.
Eur J Vasc Endovasc Surg. 2022 Jul;64(1):15-22. doi: 10.1016/j.ejvs.2022.05.005. Epub 2022 May 7.
To clarify the natural history of abdominal aortic ectasia (AAE) measuring 25 - 29 mm in maximum diameter, and to determine the optimal follow up based on the growth, risk of rupture, and overall mortality of AAE.
MEDLINE, Web of Science Core Collection, and Google Scholar.
This was a systematic review and meta-analysis of AAE in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. MEDLINE, Web of Science Core Collection, and Google Scholar were searched, with the help of a health sciences librarian, up to 11 August 2021. Studies with longitudinal outcomes of AAE (prevalence, annual growth rate, aneurysmal enlargement, rupture, aneurysm related death, and all cause mortality) were included. Meta-analyses were conducted with a random effects model RESULTS: Twelve studies describing a total of 8 369 patients were eligible. The prevalence at population based settings was 3.2% (95% confidence interval [CI] 2.4 - 4.0); annual growth rate was 0.82 mm/year (95% CI 0.20 - 1.45). The estimated risks of aortic diameters exceeding 30 mm and 55 mm in five years were 45.0% (95% CI 28.5 - 61.5) and 0.3% (95% CI 0 - 0.6) respectively, while those beyond five years were 70.2% (95% CI 46.9 - 93.6) and 5.2% (95% CI 2.2 - 8.2). The rates of rupture and aneurysm related death were minimal until five years (0.1% and 0.1%, respectively) and beyond (0.4% and 0.2%, respectively). Overall mortality was 7.5% (95% CI 3.9 - 11.0) and 17.3% (95% CI 9.5 - 25.1) up to and beyond five years. Overall mortality from three studies showed no statistical difference between AAE and aneurysms (hazard ratio 0.62, 95% CI 0.32 - 1.21; p = .16). Cancer (35.0%) and cardiovascular diseases (31.9%) were major causes of death.
AAE carries minimal risk of aneurysm related lethal events during the first five years, but a similar overall mortality risk as abdominal aortic aneurysm. Cancer and cardiovascular diseases are leading causes of death in patients with AAE.
阐明最大直径为 25-29 毫米的腹主动脉瘤的自然病史,并根据腹主动脉瘤的生长、破裂风险和总体死亡率来确定最佳随访时间。
MEDLINE、Web of Science 核心合集和 Google Scholar。
这是一项根据系统评价和荟萃分析首选报告项目(PRISMA)指南对腹主动脉瘤进行的系统评价和荟萃分析。在健康科学图书馆员的帮助下,我们在 2021 年 8 月 11 日之前检索了 MEDLINE、Web of Science 核心合集和 Google Scholar。纳入了具有腹主动脉瘤纵向结局(患病率、年增长率、瘤体增大、破裂、瘤体相关死亡和全因死亡率)的研究。采用随机效应模型进行荟萃分析。
有 12 项研究共描述了 8369 名患者,符合条件。基于人群的患病率为 3.2%(95%置信区间 [CI] 2.4-4.0);年增长率为 0.82 毫米/年(95%CI 0.20-1.45)。预计五年内主动脉直径超过 30 毫米和 55 毫米的风险分别为 45.0%(95%CI 28.5-61.5)和 0.3%(95%CI 0-0.6),而五年以上的风险分别为 70.2%(95%CI 46.9-93.6)和 5.2%(95%CI 2.2-8.2)。破裂和瘤体相关死亡的风险在五年内(分别为 0.1%和 0.1%)和五年后(分别为 0.4%和 0.2%)均较低。全因死亡率为 7.5%(95%CI 3.9-11.0)和 17.3%(95%CI 9.5-25.1),五年及五年以上均为如此。来自三项研究的总体死亡率表明,腹主动脉瘤和动脉瘤之间没有统计学差异(风险比 0.62,95%CI 0.32-1.21;p=0.16)。癌症(35.0%)和心血管疾病(31.9%)是死亡的主要原因。
在最初的五年内,腹主动脉瘤瘤体相关致死事件的风险极小,但与腹主动脉瘤的总体死亡率相似。癌症和心血管疾病是腹主动脉瘤患者死亡的主要原因。